NRP1 antagonist 1
Zilucoplan
Vesencumab
Tesidolumab
Ravulizumab
Lampalizumab
Vilobelimab
Avdoralimab
Pexelizumab
Gefurulimab
Gavilimomab
Pozelimab
Olendalizumab
Crovalimab
Riliprubart
Empasiprubart
Zoracopan
BCX 1470
Sutimlimab
PMX 205